Cardamom

NutraPedia - Evidence-Based Supplement Research

Back to Table of Contents
Health Goals: digestion inflammation heart

Research Overview

Across the abstracts, cardamom (primarily Elettaria cardamomum) is most frequently studied in the context of (i) phytochemistry and essential oil composition, (ii) broad pharmacological screening (antioxidant, antimicrobial, antidiabetic, anti-inflammatory, gastro-protective, and anticancer activities), and (iii) mechanistic “candidate pathway” research focused on specific bioactives. Reviews emphasize that cardamom capsules and cardamom essential oil contain diverse constituents (e.g., terpenoids, flavonoids, carotenoids and other volatile compounds), and that these constituents are plausibly linked to multiple biological effects. A smaller but notable set of studies extends into neuropharmacology (e.g., acetylcholinesterase inhibition and rodent neurotoxicity models) and cardiometabolic endpoints (blood pressure/endothelial function mentioned, though details are limited in the provided text). In parallel, food-safety surveillance research has examined heavy metal contamination in spices, including green cardamom, with geographic variability in Pb/Cd levels.

The strongest evidence supported by these abstracts is that cardamom has reproducible bioactive potential in preclinical and in vitro contexts—particularly antioxidant activity and enzyme/pathway interactions consistent with antidiabetic, antimicrobial, and neuroactive hypotheses (e.g., acetylcholinesterase inhibition). There is also comparatively strong support for the presence and characterization of bioactive constituents in cardamom extracts/essential oil, and for the concept that specific compounds such as cardamonin can modulate multiple signaling pathways relevant to inflammation and cancer biology (e.g., NF-κB, mTOR, Akt, STAT3, Wnt/β-catenin, COX-2), albeit largely from mechanistic and experimental literature rather than definitive clinical outcomes. The contamination literature provides evidence that exposure risk depends on origin and supply chain, with some reported Pb/Cd levels in certain regions that warrant monitoring, even when many assessed non-carcinogenic risks appear low in aggregate assessments.

Key gaps include a need for more well-controlled human clinical trials to establish efficacy, dose–response relationships, and clinically meaningful endpoints for cardiometabolic health (e.g., glycemic control, lipids, blood pressure, endothelial function), neurocognitive outcomes, and gastrointestinal indications that are prominent in traditional use. Mechanistic links proposed in related metabolic research (e.g., SIRT1/SREBP pathways relevant to lipid metabolism and diabetes complications) require direct testing with cardamom preparations to determine whether these pathways are truly engaged in vivo at dietary or supplemental exposures. Additional priorities are standardization of extracts/essential oils (chemotype, purity, stability), pharmacokinetics and safety (including interactions and long-term use), and expanded food-safety surveillance to quantify and mitigate heavy metal contamination across producing regions.

1. What conditions has Cardamom been studied for?

  • Type 2 diabetes–related cardiometabolic outcomes: In a clinical trial in people with T2DM, cardamom (3 g/day) was tested for effects on blood pressure, endothelial/inflammatory markers (sICAM-1), and anthropometrics over 8 weeks.

  • Inflammation/metabolic mediators in humans: A systematic review of “functional foods” identified cardamom among foods studied in clinical trials for inflammatory and metabolic mediator changes (without detailing cardamom-specific outcomes in the abstract).

  • Neurotoxicity/Alzheimer’s disease–like features (preclinical): Cardamom oil was studied in a rat model of aluminum chloride–induced neurotoxicity; the abstract notes relevance to acetylcholinesterase (AChE), an enzyme implicated in Alzheimer’s disease.

  • Oral/periodontal infections and inflammation (preclinical/in vitro): Cardamom fruit and seed extracts were tested against major periodontal pathogens and for anti-inflammatory activity.

  • Antibacterial, antioxidant, gastro-protective, anticancer, antidiabetic (mostly preclinical): A critical review of Elettaria cardamomum summarizes these biological activities for essential oil/extracts.

  • Heavy metal exposure risk from contaminated cardamom (food safety): A PRISMA systematic review reported lead (Pb) and cadmium (Cd) levels in some green cardamom samples (e.g., Bahrain) and assessed health risks.

  • Aquaculture stress/metabolic markers (non-human): Black cardamom (Amomum subulatum) extract was studied in fish for growth, antioxidant status, stress response, glucose, cortisol, and triglycerides.

  • Mechanistic targets relevant to lipid metabolism/diabetes (indirect): One abstract discusses SIRT1/SREBP pathways as therapeutic targets for lipid metabolism dysfunction/diabetes complications, but it does not specifically test cardamom.

2. Does it work in treating those conditions? Summarize the evidence.

  • T2DM blood pressure/endothelial inflammation (human RCT): mixed/limited evidence. In an 8-week randomized trial (n=204 total across multiple herbal arms), cardamom (3 g/day with black tea) showed no significant difference versus other herbs in effects on BP, sICAM-1, or anthropometrics, and the abstract does not report a clear within-group improvement for cardamom (whereas ginger and saffron showed within-group sICAM-1 reductions, and ginger reduced systolic BP).

  • Inflammation/metabolic mediators (human evidence exists but is not detailed here). A systematic review of clinical trials lists cardamom among foods studied for inflammatory/metabolic mediator changes, but the abstract does not provide cardamom-specific effect sizes or conclusions; therefore, efficacy cannot be confirmed from the provided text.

  • Alzheimer’s disease–like neurotoxicity (animal): suggestive but not clinical proof. The rat study rationale notes cardamom oil has reported AChE inhibitory, antioxidant, and anti-anxiety effects and tests it in an aluminum chloride neurotoxicity model. Because outcomes are not shown in the provided abstract excerpt, and it is an animal model, this is not sufficient to conclude clinical benefit for Alzheimer’s disease.

  • Periodontal pathogens/inflammation (in vitro): promising, not definitive. Cardamom fruit and seed extracts showed antibacterial activity against major periodontal pathogens and were tested for anti-inflammatory activity. This supports potential oral-health applications, but in vitro findings do not establish clinical efficacy in humans.

  • Anticancer/immune modulation (compound-focused, preclinical): preliminary. A review on cardamonin (a cardamom-derived chalcone) describes multi-target pathway effects (e.g., mTOR, NF-κB, Akt, STAT3, Wnt/β-catenin, COX-2) and selective cytotoxicity in experimental settings, but this is not equivalent to proven anticancer treatment in humans.

  • Fish growth/stress biomarkers (non-human): positive in that context only. Black cardamom extract improved growth, antioxidant enzymes, and reduced glucose/cortisol/triglycerides in fish under stress; this cannot be directly extrapolated to human therapeutic effects.

3. What health benefits does it have?

  • Antioxidant potential: Reviews of Elettaria cardamomum essential oil/extracts describe antioxidant activity; the neurotoxicity study rationale also highlights antioxidant properties of cardamom oil.

  • Antimicrobial/oral health potential: Cardamom fruit and seed extracts demonstrated antibacterial activity against periodontal pathogens in laboratory testing, suggesting possible relevance to gum/oral infections.

  • Anti-inflammatory and metabolic effects (possible, not firmly established clinically): Cardamom is included among “functional foods” studied in clinical trials for inflammatory/metabolic mediators. However, the provided T2DM trial abstract did not show clear superiority for cardamom on BP, sICAM-1, or anthropometrics.

  • Neuroactive properties (preclinical): Cardamom oil has been reported (in the animal-study rationale) to have AChE inhibitory and anti-anxiety effects, which are mechanistically relevant to cognition, but human evidence is not provided here.

  • Bioactive constituents with pharmacologic plausibility: Reviews describe essential oils, flavonoids, terpenoids, and carotenoids in cardamom; and cardamonin is highlighted as a multi-target bioactive with anti-inflammatory and anticancer pathway effects (preclinical).

4. Does it have any downsides or side effects?

  • Heavy metal contamination risk (quality/sourcing issue): A PRISMA systematic review of spices reported that green cardamom from Bahrain had relatively high levels of Pb (2.2 μg/g) and Cd (0.9 μg/g). While the review’s non-carcinogenic risk assessment generally found no oral-exposure risks across regions/spices (with an exception noted for Cd in chamomile in Turkey), the presence of Pb/Cd in some cardamom samples indicates a potential safety concern depending on origin and quality control.

  • Clinical side effects not described in the provided abstracts: The 8-week T2DM herbal trial abstract does not mention adverse events for cardamom, and the reviews emphasize potential benefits but do not provide specific rates of side effects in humans in the excerpts provided.

  • Evidence limitations: Many claimed benefits are based on reviews, in vitro work, or animal models; lack of robust human outcomes data increases uncertainty about both efficacy and real-world side-effect profiles at supplemental doses.

5. Is it beneficial or harmful for any genetic variations (pharmacogenomics)?

The provided abstracts do not report pharmacogenomic findings for cardamom (e.g., effects modified by genetic variants in drug-metabolizing enzymes, transporters, or targets). While mechanistic pathways mentioned (e.g., inflammatory signaling targets for cardamonin; SIRT1/SREBP discussed in a separate mechanistic abstract) could, in theory, vary by genotype, there is no direct evidence here linking cardamom’s benefits or harms to specific genetic variants.

References

  1. SIRT1/SREBPs-mediated regulation of lipid metabolism.
    Shan Shen, Mingyang Shen, Lirun Kuang, Keyu Yang, Shiran Wu, Xinde Liu, Yuting Wang, Yong Wang (2024) - Pharmacological research
  2. Critical Review on Nutritional, Bioactive, and Medicinal Potential of Spices and Herbs and Their Application in Food Fortification and Nanotechnology.
    Debopriya Mandal, Tanmay Sarkar, Runu Chakraborty (2023) - Applied biochemistry and biotechnology
  3. Botany, traditional uses, phytochemistry and biological activities of cardamom [Elettaria cardamomum (L.) Maton] - A critical review.
    Kaliyaperumal Ashokkumar, Muthusamy Murugan, M K Dhanya, Thomas D Warkentin (2020) - Journal of ethnopharmacology
  4. Antioxidant Activity in Extracts from
    Pura Ballester, Begoña Cerdá, Raúl Arcusa, Ana María García-Muñoz, Javier Marhuenda, Pilar Zafrilla (2023) - Molecules (Basel, Switzerland)
  5. Heavy metals in spices and herbs from worldwide markets: A systematic review and health risk assessment.
    Najla Alawadhi, Khaled Abass, Raghad Khaled, Tareq M Osaili, Lucy Semerjian (2024) - Environmental pollution (Barking, Essex : 1987)
  6. Neuroprotective Effect of Cardamom Oil Against Aluminum Induced Neurotoxicity in Rats.
    Sandip T Auti, Yogesh A Kulkarni (2019) - Frontiers in neurology
  7. Cardamonin: A new player to fight cancer via multiple cancer signaling pathways.
    Javaria Nawaz, Azhar Rasul, Muhammad Ajmal Shah, Ghulam Hussain, Ammara Riaz, Iqra Sarfraz, Saba Zafar, Muhammad Adnan, Abdul Haleem Khan, Zeliha Selamoglu (2020) - Life sciences
  8. Effect of cinnamon, cardamom, saffron and ginger consumption on blood pressure and a marker of endothelial function in patients with type 2 diabetes mellitus: A randomized controlled clinical trial.
    Paria Azimi, Reza Ghiasvand, Awat Feizi, Javad Hosseinzadeh, Maryam Bahreynian, Mitra Hariri, Hossein Khosravi-Boroujeni (2016) - Blood pressure
  9. Functional foods modulating inflammation and metabolism in chronic diseases: a systematic review.
    Julissa Luvián-Morales, Francisco Omar Varela-Castillo, Laura Flores-Cisneros, Lucely Cetina-Pérez, Denisse Castro-Eguiluz (2022) - Critical reviews in food science and nutrition
  10. Black cardamom (Amomum subulatum) extract improves growth potential, antioxidant status, immune parameters and response to crowding stress in Catla catla.
    Wazir Ali, Mahroze Fatima, Syed Zakir Hussain Shah, Noor Khan, Saima Naveed (2024) - Journal of animal physiology and animal nutrition
  11. Chyawanprash: A Traditional Indian Bioactive Health Supplement.
    Rohit Sharma, Natália Martins, Kamil Kuca, Ashun Chaudhary, Atul Kabra, Meda M Rao, Pradeep Kumar Prajapati (2019) - Biomolecules
  12. Antibacterial and anti-inflammatory activities of cardamom (Elettaria cardamomum) extracts: Potential therapeutic benefits for periodontal infections.
    Mariem Souissi, Jabrane Azelmat, Kamel Chaieb, Daniel Grenier (2020) - Anaerobe
  13. A Scoping Review of the Clinical Evidence for the Health Benefits of Culinary Doses of Herbs and Spices for the Prevention and Treatment of Metabolic Syndrome.
    Marion Mackonochie, Ana Rodriguez-Mateos, Simon Mills, Vivien Rolfe (2023) - Nutrients
  14. Recent Advances in Nutraceuticals for the Treatment of Sarcopenic Obesity.
    Young-Chan Kim, Sang-Woo Ki, Hannah Kim, Sumin Kang, Hayoon Kim, Gwang-Woong Go (2023) - Nutrients
  15. The Influence of a Nanoemulsion of Cardamom Essential Oil on the Growth Performance, Feed Utilization, Carcass Characteristics, and Health Status of Growing Rabbits under a High Ambient Temperature.
    Rehab F S A Ismail, Mahmoud A E Hassan, Mahmoud Moustafa, Mohammed Al-Shehri, Reem S Alazragi, Hanan Khojah, Ali Ali El-Raghi, Sameh A Abdelnour, Alaa M A Gad (2023) - Animals : an open access journal from MDPI
  16. Protective Effects of Cardamom in Isoproterenol-Induced Myocardial Infarction in Rats.
    Sameer N Goyal, Charu Sharma, Umesh B Mahajan, Chandragouda R Patil, Yogeeta O Agrawal, Santosh Kumari, Dharamvir Singh Arya, Shreesh Ojha (2015) - International journal of molecular sciences
  17. Ayurvedic Herbal Medicines: A Literature Review of Their Applications in Female Reproductive Health.
    Srihita Patibandla, Joshua J Gallagher, Laasya Patibandla, Ali Z Ansari, Shayaan Qazi, Samuel F Brown (2024) - Cureus
  18. Cardamom powder supplementation prevents obesity, improves glucose intolerance, inflammation and oxidative stress in liver of high carbohydrate high fat diet induced obese rats.
    Md Mizanur Rahman, Mohammad Nazmul Alam, Anayt Ulla, Farzana Akther Sumi, Nusrat Subhan, Trisha Khan, Bishwajit Sikder, Hemayet Hossain, Hasan Mahmud Reza, Md Ashraful Alam (2017) - Lipids in health and disease
  19. The effect of
    Roghayeh Yahyazadeh, Mahboobeh Ghasemzadeh Rahbardar, Bibi Marjan Razavi, Gholamreza Karimi, Hossein Hosseinzadeh (2021) - Iranian journal of basic medical sciences
  20. Coffee Phenolics and Their Interaction with Other Food Phenolics: Antagonistic and Synergistic Effects.
    Ezgi Erskine, Büşra Gültekin Subaşı, Beyza Vahapoglu, Esra Capanoglu (2022) - ACS omega


Want personalized supplement recommendations based on your genetics?
Upload Whole Genome Sequencing (WGS) raw DNA data today!
Or upload raw DNA data to get started with your free analysis!